Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of BKM120 monotherapy in metastatic endometrial cancer
2011-002576-16Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of buparlisib in endometrial cancer (EC), sponsored by ARCAGY. Primary endpoint: Non-progression rate. Started Jul 2011; status: completed.
02
Drugs
buparlisib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on 2011-002576-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002576-16.